RA Capital Management

Latest statistics and disclosures from Ra Capital Management's latest quarterly 13F-HR filing:

Companies in the Ra Capital Management portfolio as of June 2017 quarter

Company (Ticker) Portfolio Weight Share Count Change in Shares Price
Ascendis Pharma A S 17.78 +3% 5.58M 27.76
Wave Life Sciences Ltd shs 15.13 7.09M 18.60
Avexis 12.35 -19% 1.31M 82.16
Achillion Pharmaceuticals (ACHN) 7.18 13.63M 4.59
Biohaven Pharmaceutical Holding 7.02 NEW 2.45M 25.00
G1 Therapeutics 5.37 NEW 2.68M 17.44
Ignyta 4.77 +291% 4.02M 10.35
Esperion Therapeutics 3.88 +3% 731531 46.28
Myovant Sciences 3.77 +19% 2.81M 11.70
BioCryst Pharmaceuticals (BCRX) 3.29 +47% 5.16M 5.56
Ra Pharmaceuticals 2.91 1.35M 18.74
Radius Health 2.58 NEW 497157 45.23
Zogenix 2.45 -39% 1.47M 14.50
Aquinox Pharmaceuticals 2.25 -36% 1.40M 14.07
AVEO Pharmaceuticals (AVEO) 2.15 NEW 8.44M 2.22
Acorda Therapeutics (ACOR) 2.04 +83% 900259 19.70
Akebia Therapeutics 1.38 NEW 836337 14.37
Sangamo Biosciences (SGMO) 1.26 NEW 1.25M 8.80
Dicerna Pharmaceuticals 0.88 2.43M 3.17
Tg Therapeutics 0.81 700000 10.05
Kalvista Pharmaceuticals 0.50 591070 7.36
Proteon Therapeutics 0.23 NEW 1.34M 1.53

Past 13F-HR SEC Filings by Ra Capital Management

View All Filings